GW Pharmaceuticals Gets New York Clinical Trial for Kids

Governor Andrew Cuomo announced an agreement between New York State and GW Pharmaceuticals to develop a clinical trial for children with treatment-resistant epilepsy. GW Pharmaceuticals is known for its marijuana-based medicines that use the extract cannabidiol, or CBD. The FDA has already authorized 60 children in the NYU Langone Medical Center to use GW's drug Epidiolex. There are also roughly 300 children in various sites across the country that also receive the drug. NY legislators are considering legalizing medical marijuana but the bill hasn't gone to a floor vote yet.

undefined